
The COVID-19 pandemic induces very different reactions of people on the internet (https://www.cdc.gov/mmwr/volumes/70/wr/mm7002e1.htm) and in the social networks. Without following the conspiracy theories as “5G nanochip hidden in COVID vaccines” some news as “COVID vaccines induce allergic reactions” should be scientifically recognised. The picture from the 5G-nanochip whose plan goes viral on the internet is now exposed as fake and shows a guitar pedal. Quite different the recent news about allergic responses after injection of the COVID vaccine [1-3]. Is it true, and how about nanoparticles in vaccines?
Firstly, we should know that the active ingredient within the new vaccines are very sensitive molecules (the so-called mRNA) which must not only be cooled during transport but also would immediately be degraded after injection if not explicitly be stabilized by a special nano-shell. Here the principles of nanomedicine are adopted as the instable RNA-molecule is packed into a lipid layer containing stabilizing polymers (e.g. polyethylene glycol = PEG and others) [4, 5]. These polymers are part of the transport system which delivers the active agent to the cells in our body which start the anti-viral machinery. Unfortunately, such molecules may have a disadvantage because a small part of the population responds sensitive to polymers such as PEG which has been observed in 12 patients after getting the vaccine [1, 3]. The portion of sensitive people is very small but not negligible (currently more than 32 Mio. people have been vasccinated, as of January 2021), thus, it is important to know about the ingredients [please find the full list of the two recent vaccines in 3] and to discuss these with the treating physician. Scientific fact is: the size of the lipid vesicles (nano) is not of importance in relation to adverse effects. Ingredients such as the polymers of the shell around the active agent may induce problems, but the advantage of a COVID vaccination is indisputable.
If someone wants to know more about nanoparticles and vaccination, please visit the website of the Helmholtz Centre for Infection Research: https://www.helmholtz-hzi.de/en/news-events/stories/vaccination-with-nanoparticles/ .
Literature:
- de Vrieze, J (2021) Pfizer’s vaccine raises allergy concerns. Science, 371(6524): 10-11.
- Kleine-Tebbe, J et al. (2021) Severe allergic reactions to the COVID-19 vaccine – statement and practical consequences. Allergol Select, 5 26-28.
- Worm, M et al. (2021) Covid-19 vaccination and risk of anaphylaxis – Recommendations for practical management. MMW Fortschr Med, 163(1): 48-51.
- Editorial (2020) Nanomedicine and the COVID-19 vaccines. Nat Nanotechnol, 15(12): 963
- Abd Ellah, NH et al. (2020) Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19. Nanomedicine (Lond), 15(21): 2085-2102.

Weitere Spotlights
Spotlight Juli 2020: “Nanosafety – More than just regulatory processes”
Nanosafety is more than just a compulsory aspect of nanomaterials research and regulation. This research area also has great potential to drive new innovations. It is exactly this perspective that is addressed in the special issue “Rethinking Nanosafety: Harnessing Progress and Driving Innovation” by Chen et al. 2020. The article illustrates that especially in the field of […]
Read moreSpotlight November 2020: Nanotechnology in the public perception
In November, we would like to draw your attention to a publication that examines public perception of the safety of nanomaterials in Austria.It shows, that although there is generally a rather positive attitude towards nanomaterials, there are different opinions on safety issues from different social groups. Further clarification seems necessary. Despite the widespread use of […]
Read moreSpotlight February 2023: New sustainable and promising method to give cotton textiles an antiviral and antibacterial finish
Textiles have been the subject of research into functionalization for many years, especially also to repel bacteria and viruses. Since the development of nanotechnological processes, there have been many attempts to incorporate UV protection with nano-titanium dioxide, or to provide textiles with anti-bacterial properties with nanosilver (see cross-sectional text “Nanoparticles in Textiles”). But nanosilver has […]
Read moreSpotlight January 2022: Methods, models, mechanisms and metadata
For the new year, we are presenting no “classic” paper here, but would like to point out an editorial: Methods, Models, Mechanisms and Metadata: Introduction to the Nanotoxicology Collection at F1000 Research. This editorial introduces the F1000Research Nanotoxicology Collection, where best practices can be collected in the form of original research reports, including no-effect studies, […]
Read more